Current medical treatment for tuberculosis

doi:10.1136/bmj.325.7375.1282

BMJ 2002;325:1282-1286 ( 30 November )

Clinical review

Current medical treatment for tuberculosis

Edward D Chan, assistant professor of medicine, Michael D Iseman, professor of medicine.

Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206, USA

Correspondence to: E D Chan K613E, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206, USA chane@njc.org

The first 150 words of the full text of this article appear below.

Instigating effective treatment regimens in a way that improves patient adherence is vital to tackling the global resurgenceof tuberculosis

About one third of the world's population has latent tuberculosis, caused by Mycobacterium tuberculosis infection.¹ Fromthis pool, roughly 9 million cases of active tuberculosis emergeannually, resulting in 2-3 million deaths. Most new cases occurin the most populated nations $---$ India and China $---$ but the highestrates of disease are seen in sub-Saharan Africa, the Indonesianand Philippine archipelagos, Afghanistan, Bolivia, and Peru. Inthese regions case rates typically exceed 300 cases per 100 000per year. ¹ ² Although the incidence of tuberculosis declinedin North America and western Europe throughout most of the latterhalf of the 20th century, case rates have increased over the past10 years mainly because of immigration, HIV/AIDS, and the neglectof tuberculosis control programmes. ³ ⁴ One vital factor incurbing the increase of tuberculosis is the instigation of proper. . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Articles

Pneumonia: ... and to tuberculosis as differential diagnosis in community acquired pneumonia: Takeharu Koga and Hisamichi Aizawa
BMJ 2006 332: 1214. [Extract] [Full Text]

Current medical treatment for tuberculosis: Lawrence P Ormerod, Ian A Campbell, Peter D O Davies, Atle Fretheim, Michael D Iseman, Edward Chan, Ruth J Whitfield, Rosemary Khan, Anne Smith, and Charlotte F J Rayner
BMJ 2003 326: 550. [Extract] [Full Text]

Global resurgence of tuberculosis is troubling
BMJ 2002 325: 0. [Full Text]

This article has been cited by other articles:

van den Boogaard, J., Kibiki, G. S., Kisanga, E. R., Boeree, M. J., Aarnoutse, R. E. (2009). New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development. Antimicrob. Agents Chemother. 53: 849-862 [Full text]
Kurabachew, M., Lu, S. H. J., Krastel, P., Schmitt, E. K., Suresh, B. L., Goh, A., Knox, J. E., Ma, N. L., Jiricek, J., Beer, D., Cynamon, M., Petersen, F., Dartois, V., Keller, T., Dick, T., Sambandamurthy, V. K. (2008). Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. J Antimicrob Chemother 62: 713-719 [Abstract] [Full text]
Chan, R. C. Y., Hui, M., Chan, E. W. C., Au, T. K., Chin, M. L., Yip, C. K., AuYeang, C. K. W., Yeung, C. Y. L., Kam, K. M., Yip, P. C. W., Cheng, A. F. B. (2007). Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 59: 866-873 [Abstract] [Full text]
Clark, P. M., Karagoz, T., Apikoglu-Rabus, S., Izzettin, F. V. (2007). Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm 64: 497-505 [Abstract] [Full text]
Koga, T., Aizawa, H. (2006). Pneumonia: ... and to tuberculosis as differential diagnosis in community acquired pneumonia.. BMJ 332: 1214-1214 [Full text]
Di Perri, G., Bonora, S. (2004). Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?. J Antimicrob Chemother 54: 593-602 [Abstract] [Full text]
Ormerod, L. P, Campbell, I. A, Davies, P. D O, Fretheim, A., Iseman, M. D, Chan, E., Whitfield, R. J, Khan, R., Smith, A., Rayner, C. F J (2003). Current medical treatment for tuberculosis. BMJ 326: 550-550 [Full text]

Rapid Responses:

Read all Rapid Responses

Addressing the "real issues" in tuberculosis: Dr Susheel Oommen John
bmj.com, 30 Nov 2002 [Full text]
Pitfalls of Non Systematic Reviews of TB treatment: Merrick Zwarenstein
bmj.com, 30 Nov 2002 [Full text]
Request for clarification: Ross E Upshur
bmj.com, 30 Nov 2002 [Full text]
Few words about DOTS in Russia: Anna Belozerova
bmj.com, 1 Dec 2002 [Full text]
Capturing health systems complexity: drawing lessons from tuberculosis control programmes: Richard J Coker, et al.
bmj.com, 1 Dec 2002 [Full text]
Tuberculosis in India: Dr S K Agarwal
bmj.com, 2 Dec 2002 [Full text]
The (not so) hidden factor in Tubercular treatment.: Ananda Chapagain
bmj.com, 4 Dec 2002 [Full text]
More weight on observational studies than randomised controlled trials?: Atle Fretheim, et al.
bmj.com, 6 Dec 2002 [Full text]
Contribution of new entrant screening to tuberculosis control in South West London: Ruth J Whitfield, et al.
bmj.com, 12 Dec 2002 [Full text]
Response to Currrent Medical Treatment for Tuberculosis: Lawrence P Ormerod, et al.
bmj.com, 13 Dec 2002 [Full text]
current medical treatment for tuberculosis: G.N. Malavige
bmj.com, 13 Dec 2002 [Full text]
Current medical treatment for tuberculosis.:Extra Box (Patient Information): Ms Sayennah Roberts
bmj.com, 14 Jul 2003 [Full text]